Galactorrhea

Amenorrhea & Anovulation
Andrea Chymiy, MD
Amenorrhea&Anovulation.ppt

Infertility, oligomenorrhea/amenorrhea, galactorrhea
emergency_lecture_series/Pituitary Adenoma.ppt

Board Pearls in Endocrinology
Rey Vivo, MD
Endo_pearls1.ppt

Puberty
Jennifer E. Dietrich MD, MSc
Puberty2.ppt

Cardiology Review: HTN
Julia Akaah M.D.
CardiologyReview2.ppt

Endocrinology, Diabetes, and Metabolism
Rob Sargis
Resident_Board_Review.ppt

Hyperprolactinemia
Hyperprolactinemia.ppt

Benign Breast Problems
Folake Falaki, MD
BenignBreast.ppt

Menstrual Disorders:
Excessive Vaginal Bleeding, Secondary Amenorrhea and Primary Amenorrhea
Betsy Pfeffer MD
MenstrualDisorders.ppt

Pituitary Adenomas
Elaine Sunderlin, MD
Pituitary Adenomas.ppt

Hypothyroidism - Signs and Symptoms
Thyroid.ppt

Adolescent Board Review
Adolescent Board Review.ppt

Breast Mass
Lori F Gentile, MD
Mass_Gentile.ppt

Hormonal and Sexual Concerns in Schizophrenia
Deanna L. Kelly, PharmD., BCPP
Hormonal and Sexual Concerns in Schizophrenia.ppt

Elevated or Depressed Hormone Levels
Elevated or Depressed Hormone Levels.ppt

Drugs Related to Hypothalamic and Pituitary Function
Drugs Related to Hypothalamic and Pituitary Function.ppt

Schizophrenia
Schizophrenia.ppt

Morbidity and Mortality Conference
Ann Marie Lam,
PituitaryAdenoma.ppt

Galactorrhea, breast enlargement
M. Catalina Melo, M.D.
Galactorrhea, breast enlargement.ppt

Galactorrhea, amenorrhea, and infertility
Prof. Borrero
Galactorrhea, amenorrhea, and infertility.ppt

Gynecology Board Review
Gynecology Board Review.ppt

Endocrine Board Review
Ria Dancel, MD
Endocrine Board Review.ppt
190 scholarly articles on Galactorrhea free access

1. Antipsychotic-induced euprolactinemic galactorrhea in an adolescent girl: a case report.
2. Macroprolactinemia and intermediate hyperprolactinemia: clinical manifestations and image.
3. Galactorrhea during duloxetine treatment: a case report.
4. Marked mydriasis and neuritis nervi optici associated with galactorrhea following citalopram treatment: a case report and discussion.
5. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.
6. High doses alprazolam induced amenorrhoea and galactorrhoea.
7. Hyperprolactinaemia with amisulpride.
8. Bilateral angle-closure glaucoma in a young female receiving cabergoline: a case report.
9. Dose-dependent galactorrhea with quetiapine.
10. Hyperprolactinemia with normal serum prolactin: Its clinical significance.
11. A case of paroxetine-induced galactorrhoea with normal serum prolactin level.
12. A case of galactorrhea with escitalopram: a biopsychosocial phenomenon.
13. Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma.
14. Symptomatic hypopituitarism revealing primary suprasellar lymphoma.
15. A possible new syndrome with double endocrine tumors in association with an unprecedented type of familial heart-hand syndrome: a case report.
16. Ziprasidone-induced galactorrhea in an adolescent female: a case report.
17. Hyperprolactinemia with antipsychotic drugs in children and adolescents.
18. Actual status of veralipride use.
19. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
20. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant.
21. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.
22. Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder.
23. Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
24. Multiple Endocrine Neoplasia Type 1.
25. Lactation associated with a pituitary tumour in a man.
26. Nipple discharge screening.
27. A case of galactorrhea associated with excitalopram.
28. Extensive personal experience. Validation of prolactin levels in menstrual disorders and in prolactinomas.
29. Axillary accessory breast associated with galactorrhea in an adolescent girl.
30. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
31. Galactorrhea associated with juvenile systemic lupus erythematosus: a review of the role of prolactin.
32. Sellar lesion: not always a pituitary adenoma.
33. A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO.
34. Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment.
35. Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.
36. Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma.
37. Hyperprolactinaemia with amisulpride.
38. Expression of adrenocorticotropic hormone, prolactin and transcriptional factors in clinically nonfunctioning pituitary adenoma.
39. Risperidone-induced polydipsia and polyphagia associated with galactorrhea, abdominal pain, and rapid weight gain in an adolescent Hispanic female.
40. Long-term management of prolactinomas.
41. Low dose quetiapine induced galactorrhoea: a case report.
42. Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent.
43. Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia.
44. Clinical and Epidemiological Characteristics of Pituitary Tumours using a Web-based Pituitary Tumour Registry in Oman.
45. Galactorrhoea and the use of selective serotonin reuptake inhibitors.
46. A young female with galactorrhoea and sudden onset chest pain.
47. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
48. Incidence of galactorrhea in young women using Depot-Medroxyprogesterone Acetate.
49. Galactorrhoea may be associated with methadone use.
50. A case of a prolactinoma resistant to dopamine agonists.
51. Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances.
52. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay.
53. Acupuncture-induced galactorrhoea--a case report.
54. The impact on clinical practice of routine screening for macroprolactin.
55. Diagnosis and treatment of pituitary adenomas.
56. Primary hypothyroidism mimicking pituitary macroadenoma.
57. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
58. Hyperprolactinemia associated with risperidone: a case report and review of literature.
59. Postpartum amenorrhoea-galactorrhoea.
60. Information from your family doctor. Galactorrhea: what you should know about it.
61. Diagnosis and management of galactorrhea.
62. A case of cystic lymphocytic hypophysitis with cacosmia and hypopituitarism.
63. Hypopituitarism and amenorrhea-galactorrhea syndrome caused by thrombosis of both internal carotid artery and giant intrasellar aneurysm: case report.
64. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.
65. Postpartum amenorrhoea-galactorrhoea associated with hyperprolactinaemia and pituitary enlargement in primary hypothyroidism.
66. From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.
67. Transvaginal ultrasound detection of multifollicular ovaries in non-hirsute ovulatory women.
68. Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults.
69. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
70. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
71. Macroprolactinemia: a new cause of hyperprolactinemia.
72. Macroprolactin-a cause of pseudohyperprolactinaemia.
73. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review.
74. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
75. Nipple piercing and hyperprolactinemia.
76. Optic neuromyelitis syndrome in Brazilian patients.
77. Galactorrhoea following acupuncture.
78. Galactorrhoea in a 16 year old girl with a large sellar mass.
79. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.
80. Silent somatotroph adenoma, detected by catalyzed signal amplification and non-radioisotopic in situ hybridization.
81. Benign breast disease: when to treat, when to reassure, when to refer.
82. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
83. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
84. Information from your family doctor. Galactorrhea.
85. Evaluation and treatment of galactorrhea.
86. The 'hook effect' on serum prolactin estimation in a patient with macroprolactinoma.
87. The spectrum and significance of primary hypophysitis.
88. Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation.
89. Effect of risperidone on prolactinoma growth in a psychotic woman.
90. Detection of a silent pituitary somatotroph adenoma in a patient with amenorrhea and/or galactorrhea: paradoxical response of GH in TRH or GnRH provocation test.
91. Galactorrhoea and pituitary mass: a typical prolactinoma?
92. Lymphocytic hypophysitis and infundibuloneurohypophysitis; clinical and pathological evaluations.
93. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst.
94. Large empty sella with an intrasellar herniation of an elongated third ventricle. Case report.
95. Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?
96. Radiology rounds. Pituitary microadenoma (prolactinoma).
97. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.
98. Physiological secretion of chemokines in human breast milk.
99. An overweight woman with galactorrhoea.
100. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.
101. Non-puerperal lactation associated with antidepressant drug use.
102. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
103. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment.
104. Radioiodine breast uptake in nonbreastfeeding women: clinical and scintigraphic characteristics.
105. Pituitary tumors. Current concepts in diagnosis and management.
106. Pituitary function in patients with Rathke's cleft cyst: significance of surgical management.
107. Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
108. Primary low cerebrospinal fluid pressure syndrome associated with galactorrhea.
109. Acromegaly with hyperprolactinemia developed after bilateral adrenalectomy in a patient with Cushing's syndrome due to adrenocortical nodular hyperplasia.
110. Empty sella developing during thyroxine therapy in a patient with primary hypothyroidism and hyperprolactinaemia.
111. Suprasellar ectopic pituitary adenoma presenting as cranial diabetes insipidus.
112. A pituitary specific point mutation of codon 201 of the Gs alpha gene in a pituitary adenoma of a patient with multiple endocrine neoplasia (MEN) type 1.
113. Hyperprolactinemia in Women of Reproductive Age: Etiology, diagnosis, and management.
114. A coaxial technique for performing galactography.
115. Massive prolactinoma with galactorrhoea in a prepubertal boy.
116. A pituitary thyrotrophinoma causing thyrotoxicosis and amenorrhoea/galactorrhoea: studies of alpha-subunit in the tumour and in blood.
117. Alveolar soft-part sarcoma: a hormone-sensitive tumour?
118. Unstimulated thyroid function indices of Nigerians with secondary amenorrhea.
119. Gallium-67 breast uptake in a patient with hypothalamic granuloma (sarcoid).
120. 13 trisomy born to a mother treated with bromocriptine: incidental or not?
121. A combined anterior pituitary stimulation test: experience with 285 individuals.
122. Galactorrhea in subclinical hypothyroidism.
123. Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea.
124. Syndrome of galactorrhea, amenorrhea, and obesity as possible indicators of prolactinoma: a case study approach.
125. Primary hypothyroidism presenting as amenorrhoea and galactorrhoea with hyperprolactinaemia and pituitary enlargement.
126. Primary hypothyroidism presenting as amenorrhoea and galactorrhoea with hyperprolactinaemia and pituitary enlargement.
127. Anestrus and spontaneous galactorrhea in a hypothyroid bitch.
128. Treatment of presumed prolactinoma by transsphenoidal operation: early and late results.
129. Galactorrhoea amenorrhoea syndrome due to internal carotid artery aneurysm.
130. Pituitary microadenomas: diagnostic and therapeutic trends.
131. Galactorrhoea following hypophysectomy in a boy with a prolactinoma.
132. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
133. Treatment of prolactinomas with megavoltage radiotherapy.
134. Parasellar cavernous hemangioma presenting with hyperprolactinemia. Case report.
135. Prolactin-secreting pituitary adenomas.
136. A sparsely granulated, nonsecreting adenoma of the pars intermedia associated with galactorrhea in a male rhesus monkey (Macaca mulatta).
137. Galactorrhoea as side effect of domperidone.
138. Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy.
139. Pseudoprolactinomas.
140. Therapeutic effect on galactorrhea and sterility in prolactin-secreting pituitary adenomas (author's transl).
141. Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy.
142. Amenorrhoea, galactorrhoea, and hyperprolactinaemia induced by methyldopa.
143. Galactorrhoea after withdrawal of bromocriptine.
144. Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment.
145. D penicillamine and breast enlargement.
146. Hyperprolactinaemia--investigation and results of treatment.
147. Galactorrhoea following surgical procedures to the chest wall: the role of prolactin.
148. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. Secondary amenorrhea.
149. Neurosurgery-epitomes of progress: galactorrhea, amenorrhea: an algorithm.
150. Effect of sex steroid hormones on the serum prolactin concentration.
151. Thyrotropin releasing hormone, somatostatin, and galactorrhea.
152. Prolactin responses to cimetidine.
153. Pluridirectional tomography in the evaluation of pituitary tumors.
154. Post-pill amenorrhoea.
155. Inhibition of stress-induced hyperprolactinaemia.
156. Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma.
157. Radioimmunoassay of human homologous prolactin in serum with commercially available reagents.
158. The association of Ga-67 and lactoferrin.
159. Metoclopramide hydrochloride and galactorrhea.
160. Prolactin and human reproduction.
161. Raised serum prolactin levels associated with hirsutism and amenorrhoea.
162. An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.
163. Diabetes insipidus and galactorrhea caused by histiocytosis X.
164. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
165. Raised serum prolactin levels in amenorrhoea.
166. Prolactin studies in "functionless" pituitary tumours.
167. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
168. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.
169. Amenorrhoea after discontinuing combined oestrogen-progestogen oral contraceptives.
170. Amenorrhœa and galactorrhœa.
171. Secondary amenorrhoea following oral contraceptiion--causal or coincidental?
172. Effect of cyclophenyl and clomiphene on excretion of urinary LH.
173. The effect of levodopa on galactorrhea in the Forbes-Albright syndrome.
174. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.
175. Tranquillizer-induced galactorrhea.
176. Galactorrhoea.
177. Functional evaluation of prolactin secretion: a guide to therapy.
178. Amenorrhea after the pill.
179. A radioimmunoassay for human prolactin.
180. Human prolactin: measurement in plasma by in vitro bioassay.
181. Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin.
182. Treatment of non-puerperal galactorrhoea with an ergot alkaloid.
183. Plasma prolactin activity in inappropriate lactation.
184. Breast secretion of 99mTc in the amenorrhea-galactorrhea syndrome.
185. Chiari-Frommel syndrome as a part of the Zollinger-Ellison multiple endocrine adenomatosis complex.
186. Biochemical and pharmacologic effects of alpha-methyltyrosine in man.
187. Current concepts in the treatment of anovulation.
188. Acromegaly: a review of 100 cases.
189. Galactorrhoea.
190. A Case of Galactorrhoea.